688247 宣泰醫藥
按盤價 
9.020 +1.500 (+19.947%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.274 | 3.702 | 10.285 | 5.116 | 9.873 |
| 總資產報酬率 ROA (%) | 1.145 | 3.284 | 9.073 | 4.534 | 8.456 |
| 投入資產回報率 ROIC (%) | 1.239 | 3.607 | 9.952 | 4.890 | 9.309 | 邊際利潤分析 |
| 銷售毛利率 (%) | 38.976 | 39.418 | 51.631 | 55.893 | 71.229 |
| 營業利潤率 (%) | 15.786 | 12.388 | 28.123 | 23.014 | 40.043 |
| 息稅前利潤/營業總收入 (%) | 20.741 | 11.599 | 26.534 | 19.592 | 35.942 |
| 淨利潤/營業總收入 (%) | 17.519 | 10.633 | 24.960 | 20.367 | 37.539 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 65.929 | 97.946 | 89.804 | 81.647 | 65.801 |
| 價值變動淨收益/利潤總額(%) | 3.359 | 21.098 | 8.477 | 17.228 | 22.344 |
| 營業外收支淨額/利潤總額(%) | 18.778 | -3.719 | -1.266 | -4.578 | -1.699 | 償債能力分析 |
| 流動比率 (X) | 10.984 | 11.269 | 9.462 | 10.494 | 10.591 |
| 速動比率 (X) | 10.236 | 10.395 | 8.469 | 9.562 | 10.264 |
| 資產負債率 (%) | 10.010 | 10.160 | 12.406 | 11.116 | 11.638 |
| 帶息債務/全部投入資本 (%) | -1.452 | -2.148 | -3.390 | -0.826 | -0.377 |
| 股東權益/帶息債務 (%) | -6,689.812 | -4,534.354 | -2,875.378 | -11,620.942 | -25,208.639 |
| 股東權益/負債合計 (%) | 898.967 | 884.206 | 706.049 | 799.583 | 759.286 |
| 利息保障倍數 (X) | 15.886 | -33.714 | -21.447 | -8.114 | -10.472 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.773 | 73.955 | 59.615 | 78.167 | 76.120 |
| 存貨周轉天數 (天) | 107.308 | 116.409 | 136.038 | 155.124 | 176.402 |
| 備註： | 即時報價更新時間為 01/07/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
